FY2025 · period end Jun '25 · from the 10-K filed Aug 22, 2025
| Metric | FY25Jun '25 | FY24Jun '24 | FY23Jun '23 | FY22Jun '22 | FY21Jun '21 |
|---|---|---|---|---|---|
| Revenue | $19.85B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0000076334-26-000073 | Mar 31, 2026 | May 1, 2026 | May 1, 2026 11:57 UTC | EDGAR |
| 8-K | 0000076334-26-000070 | Apr 30, 2026 | Apr 30, 2026 | Apr 30, 2026 11:59 UTC | EDGAR |
| 8-K | 0001193125-26-110795 | Mar 13, 2026 | Mar 17, 2026 | Mar 17, 2026 20:10 UTC | EDGAR |
| 10-Q | 0000076334-26-000008 | Dec 31, 2025 | Jan 30, 2026 | Jan 30, 2026 13:03 UTC | EDGAR |
| 8-K | 0000076334-26-000005 | Jan 29, 2026 | Jan 29, 2026 | Jan 29, 2026 12:59 UTC | EDGAR |
| 8-K | 0001193125-25-314164 | Dec 10, 2025 | Dec 10, 2025 | Dec 10, 2025 21:05 UTC | EDGAR |
| 8-K | 0001193125-25-275641 | Nov 10, 2025 | Nov 12, 2025 | Nov 12, 2025 11:06 UTC | EDGAR |
| 10-Q | 0000076334-25-000071 | Sep 30, 2025 | Nov 7, 2025 | Nov 7, 2025 12:51 UTC | EDGAR |
Direct links to SEC EDGAR. PH has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Net Cash Provided by (Used in) Operating Activities·Q1 2015
Major restatementwas$5M
Revised up in a 10-Q. Any P/OCF built on the original was 75.1% too high.
Operating Income (Loss)·Q2 2016
Major restatementwas$384M
Revised down in a 10-Q.
Operating Income (Loss)·Q3 2016
Major restatementwas$391.6M
Revised down in a 10-Q.
Operating Income (Loss)·FY 2018
Notable restatementwas$2.2B
Revised down in a 10-K.
Operating Income (Loss)·Q1 2017
Notable restatementwas$483.9M
Revised up in a 10-Q.
Operating Income (Loss)·Q1 2018
Notable restatementwas$591.1M
Revised down in a 10-Q.
PH is not the only one.
See every restatement we've found across the market — or get an alert the next time PH revises a number.
Restatements are detected by comparing every vintage of a fact across all of Parker-Hannifin Corp's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows PH's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Parker-Hannifin Corp — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on PH yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on PH and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $19.07B |
| $15.86B |
| $14.35B |
| Gross Profit | $7.32B | $7.13B | $6.43B | $5.31B | $4.74B |
|---|
| Operating Income | $4.35B | $4.07B | $3.40B | $2.98B | $2.46B |
|---|
| Net Income | — | $2.84B | $2.08B | $1.32B | $1.75B |
|---|
| EPS (Diluted) | $27.12 | $21.84 | $16.04 | $10.09 | $13.35 |
|---|
| Metric | FY25Jun '25 | FY24Jun '24 | FY23Jun '23 | FY22Jun '22 | FY21Jun '21 |
|---|---|---|---|---|---|
| Total Assets | $29.49B | $29.30B | $29.96B | $25.94B | $20.34B |
| Total Liabilities | $15.80B | $17.22B | $19.63B | $17.08B | $11.93B |
| Stockholders' Equity | $13.69B | $12.08B | $10.34B | $8.86B | $8.41B |
| Cash & Equivalents | $0.47B | $0.42B | $0.47B | $6.65B | $0.73B |
| Total Debt | $7.49B | $7.16B | $8.80B | — | — |
| Metric | FY25Jun '25 | FY24Jun '24 | FY23Jun '23 | FY22Jun '22 | FY21Jun '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3.78B | $3.38B | $2.98B | $2.44B | $2.58B |
| Capital Expenditures | $0.43B | $0.40B | $0.38B | $0.23B | $0.21B |
| Free Cash Flow | $3.34B | $2.98B | $2.60B | $2.21B | $2.37B |
| Metric | FY25Jun '25 | FY24Jun '24 | FY23Jun '23 | FY22Jun '22 | FY21Jun '21 |
|---|---|---|---|---|---|
| Gross Margin | 36.9% | 35.8% | 33.7% | 33.5% | 33.1% |
| Operating Margin | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% |
| Net Margin | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% |
| Return on Equity | 24.1% | 25.4% | 21.7% | 15.2% | 23.8% |
| Return on Assets | 10.5% | 9.6% | 7.5% | 5.7% | 8.7% |
| Debt / Equity | 0.55× | 0.59× | 0.85× | 1.49× | 0.78× |
